These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6233382)

  • 21. Immunoregulatory T cell circuits in man. Identification of a distinct T cell subpopulation of the helper/inducer lineage that amplifies the development of alloantigen-specific suppressor T cells.
    Damle NK; Mohagheghpour N; Kansas GS; Fishwild DM; Engleman EG
    J Immunol; 1985 Jan; 134(1):235-43. PubMed ID: 3155461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppressor T cells in systemic lupus erythematosus: lack of defective in vitro suppressor cell generation in patients with active disease.
    Tsokos GC; Balow JE
    J Clin Lab Immunol; 1982 Jun; 8(2):83-90. PubMed ID: 6213778
    [No Abstract]   [Full Text] [Related]  

  • 23. Cellular interactions in the human T-T autologous mixed lymphocyte reaction.
    Gupta S
    Behring Inst Mitt; 1983 May; (72):101-6. PubMed ID: 6242329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective immunosuppression with anti-interleukin 2 receptor-targeted therapy: helper and suppressor cell activity in rat recipients of cardiac allografts.
    Kupiec-Weglinski JW; Padberg W; Uhteg LC; Ma L; Lord RH; Araneda D; Strom TB; Diamantstein T; Tilney NL
    Eur J Immunol; 1987 Mar; 17(3):313-9. PubMed ID: 2952511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The interleukin 2 secretion defect in vitro in systemic lupus erythematosus is reversible in rested cultured T cells.
    Huang YP; Miescher PA; Zubler RH
    J Immunol; 1986 Dec; 137(11):3515-20. PubMed ID: 2946762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease.
    Via CS; Sharrow SO; Shearer GM
    J Immunol; 1987 Sep; 139(6):1840-9. PubMed ID: 2957440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of the immunoreactivity of a T-lymphocyte subpopulation by neutrophil-released prostaglandin.
    Niwa Y; Sakane T; Fukuda Y; Miyachi Y; Kanoh T
    J Clin Lab Immunol; 1985 May; 17(1):37-44. PubMed ID: 2931529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [T cell functions in rheumatic diseases].
    Sakane T; Takada S
    Ryumachi; 1982 Aug; 22(4):329-38. PubMed ID: 6217560
    [No Abstract]   [Full Text] [Related]  

  • 29. Restoration of an early, progressive defect in responsiveness to T-cell activation in lupus mice by exogenous IL-2.
    Huang FP; Stott DI
    Autoimmunity; 1993; 15(1):19-29. PubMed ID: 8218827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional heterogeneities among concanavalin A-activated OKT4+ and OKT8+ cells by using autologous erythrocyte rosette technique.
    Takada S; Ueda Y; Murakawa Y; Suzuki N; Sakane T
    J Clin Invest; 1983 Dec; 72(6):2060-71. PubMed ID: 6227636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Disturbance of immunogenesis in patients with systemic lupus erythematosus].
    Adamian NV; Solov'ev SK; Gambarov SS; Alekseev LP
    Ter Arkh; 1989; 61(5):43-5. PubMed ID: 2528836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cellular basis of the impaired autologous mixed lymphocyte reaction in patients with systemic lupus erythematosus.
    Kuntz MM; Innes JB; Weksler ME
    J Clin Invest; 1979 Jan; 63(1):151-3. PubMed ID: 153913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defects of autologous mixed lymphocyte reaction-activated immunoregulatory T cells in patients with systemic lupus erythematosus.
    Koide J; Takeuchi T; Hosono O; Takano M; Abe T
    Scand J Immunol; 1987 Oct; 26(4):363-9. PubMed ID: 2961048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunologic effects of plasmapheresis synchronized with pulse cyclophosphamide in systemic lupus erythematosus.
    Dau PC; Callahan J; Parker R; Golbus J
    J Rheumatol; 1991 Feb; 18(2):270-6. PubMed ID: 1827161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Depressed effector activity of OKT4+ and OKT8+ T cell subsets in lectin-dependent cell-mediated cytotoxicity to HEP-2 cells in patients with systemic lupus erythematosus.
    Perl A; Gonzalez-Cabello R; Gergely P
    J Clin Lab Immunol; 1984 Oct; 15(2):95-100. PubMed ID: 6240539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune status in Crohn's disease. VI. Immunoregulation evaluated by multiple, distinct T-suppressor cell assays of lymphocyte proliferation, and by enumeration of immunoregulatory T-lymphocyte subsets.
    Auer IO; Röder A; Fröhlich J
    Gastroenterology; 1984 Jun; 86(6):1531-43. PubMed ID: 6232166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of human T lymphocyte E rosette formation by neutrophils and hydrogen peroxide. Differential sensitivity between helper and suppressor T lymphocytes.
    Staite ND; Messner RP; Zoschke DC
    J Immunol; 1987 Oct; 139(7):2424-30. PubMed ID: 2958549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human epidermal cells from ultraviolet light-exposed skin preferentially activate autoreactive CD4+2H4+ suppressor-inducer lymphocytes and CD8+ suppressor/cytotoxic lymphocytes.
    Baadsgaard O; Fox DA; Cooper KD
    J Immunol; 1988 Mar; 140(6):1738-44. PubMed ID: 2964481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T-lymphocyte subsets in primary and secondary glomerulonephritis.
    Fornasieri A; Sinico R; Fiorini G; Goldaniga D; Colasanti G; Vendemia F; Gibelli A; D'Amico G
    Proc Eur Dial Transplant Assoc; 1983; 19():635-41. PubMed ID: 6224213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic lupus erythematosus with deficiency of the T4 epitope on T4 helper/inducer cells.
    N Engl J Med; 1985 Dec; 313(24):1544-5. PubMed ID: 2415819
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.